Meath man Robbie Connell was diagnosed with prostate cancer at 52 after a routine blood test showed elevated levels, despite ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a significant ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Maughan discussing a prospective trial of a structured exercise program to lessen fatigue in patients with ...